CAMBRIDGE, MA / ACCESS Newswire / October 19, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced data regarding two of its investigational influenza candidates will be presented at IDWeek 2025, ...

Moderna, Inc. remains under pressure in 2025, despite recent next-gen COVID vaccine approval & cancer vaccine trial. Learn ...

Discover whether Moderna or BioNTech offers better long-term investment potential as both pivot from COVID-19 to innovative ...

Moderna's decision not to diversify outside of COVID has hurt its business substantially. The company is still generating ...

Over the past five years, 800 million people worldwide have been infected with COVID-19. The death toll has reached 7 million. Even now, deaths continue to occur. COVID-19 is now trending toward ...

After weeks of confusion, approval by CDC and its acting director mean most Nebraskans can get COVID-19 vaccines after consulting with a health care provider, including pharmacists.

A school district balked at the request for the Supreme Court to micromanage California’s schools’ health policy on the ...

Flu season is here and a covid uptick is around the corner. Two infectious diseases experts offer their tips on how to plan for vaccination against those viruses.

In August, the U.S. Food and Drug Administration approved the new COVID-19 booster shots, but with certain restrictions.

Pfizer Chief Executive Officer Albert Bourla said that vaccines are harder to get approved right now as Health Secretary ...

Alongside the new COVID-19 vaccination guidelines, the CDC has made adjustments to its recommendations for toddler ...

Decades of immunization progress is backsliding, an NBC News data investigation reveals, threatening the safety of children in America, burdening schools and hindering public health. A monthslong NBC ...